Related Experiment Video
Updated: Jun 20, 2025
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
MiR-539-3p Alleviates Apoptosis and Extracellular Matrix Degradation in Chondrocytes of Childhood-Onset
1Department of Neonatal, Luzhou People's Hospital, Zhangba Tianfu Garden Community, Luzhou City, Sichuan Province, China. huang_yanayna22@yeah.net.
Abstract:
Recent research has identified that miR-539-3p impedes chondrogenic differentiation, yet its specific role and underlying mechanisms in childhood-onset osteoarthritis (OA) remain unclear. This study found that miR-539-3p levels were considerably lower in cartilage samples derived from childhood-onset OA patients compared to the control group. Enhancing miR-539-3p expression or suppressing RUNX2 expression notably reduced apoptosis, inflammation, and extracellular matrix (ECM) degradation in OA chondrocytes. In contrast, reducing miR-539-3p or increasing RUNX2 had the opposite effects. RUNX2 was confirmed as a direct target of miR-539-3p. Further experiments demonstrated that miR-539-3p targeting RUNX2 effectively lessened apoptosis, inflammation, and ECM degradation in OA chondrocytes, accompanied by changes in key molecular markers like reduced caspase-3 and matrix etallopeptidase 13 (MMP-13) levels, and increased B-cell lymphoma 2 (Bcl-2) and collagen type X alpha 1 chain (COL2A1). This study underscores the pivotal role of miR-539-3p in alleviating inflammation and ECM degradation in childhood-onset OA through targeting RUNX2, offering new insights for potential therapeutic strategies against this disease.
Insights
Low miR-539-3p levels are linked to childhood osteoarthritis. Increasing miR-539-3p or reducing RUNX2 alleviates chondrocyte apoptosis, inflammation, and extracellular matrix degradation in osteoarthritis.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Childhood-onset osteoarthritis (OA) pathogenesis is not fully understood.
- The role of microRNA-539-3p (miR-539-3p) in OA, particularly in pediatric cases, requires elucidation.
- Previous studies suggest miR-539-3p may impede chondrogenic differentiation.
Purpose of the Study:
- To investigate the role and mechanisms of miR-539-3p in childhood-onset OA.
- To determine the relationship between miR-539-3p and RUNX2 in OA chondrocytes.
- To explore potential therapeutic targets for childhood OA.
Main Methods:
- Quantitative analysis of miR-539-3p levels in patient cartilage samples.
- In vitro experiments manipulating miR-539-3p and RUNX2 expression in OA chondrocytes.
- Assessment of apoptosis, inflammation, and extracellular matrix (ECM) degradation markers.
- Luciferase reporter assays to confirm direct targeting of RUNX2 by miR-539-3p.
Main Results:
- miR-539-3p levels were significantly lower in childhood-onset OA cartilage compared to controls.
- Upregulating miR-539-3p or downregulating RUNX2 reduced apoptosis, inflammation, and ECM degradation in OA chondrocytes.
- RUNX2 was identified as a direct target of miR-539-3p.
- miR-539-3p targeting RUNX2 decreased caspase-3 and MMP-13, while increasing Bcl-2 and COL2A1.
Conclusions:
- miR-539-3p plays a protective role in childhood-onset OA by targeting RUNX2.
- This interaction mitigates chondrocyte apoptosis, inflammation, and ECM degradation.
- miR-539-3p represents a potential therapeutic target for childhood OA.
More Related Videos
08:42Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants
Published on: January 7, 2019
08:55Fabrication and Characterization of Layer-By-Layer Janus Base Nano-Matrix to Promote Cartilage Regeneration
Published on: July 6, 2022
